Newborn biobetter, biosimilar maker Mabpharm pitches the latest biotech IPO in Hong Kong
The latest biotech to IPO in Hong Kong didn’t exist three months ago.
To be sure, the team that is now at Mabpharm has been …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
